Latest Breaking News On - Novo nordisk india - Page 1 : comparemela.com

Effect of a multicomponent quality improvement strategy on sustained achievement of diabetes care goals and macrovascular and microvascular complications in South Asia at 6 5 years follow-up: Post hoc analyses of the CARRS randomized clinical trial

Nikhil Tandon and colleagues explore the impact of a quality improvement strategy for patients with type 2 diabetes 6.5 years after its implementation for the CARRS randomised trial.

United kingdomUnited statesAndhra pradeshNew delhiTamil naduManojd chadhaCharul aroraPrem paisRaji devarajanRamachandra reddyVaibhavi mungekarKavita singhNikhilm bhagwatVivek mathewPradeep venkateshKm venkat narayan

Why pharma majors are rushing to put anti-obesity drugs on Indian shelves

As the market for anti-obesity drugs in India grows rapidly, pharma majors like Dr. Reddy's, Zydus, and Sun Pharma are competing to quickly enter the market with weight-loss drugs - Issue Date: Jan 07, 2024

Anoop misraEli lilly mounjaroPradeep chowbeyNovo nordiskSukhvinder singh sagguSheetal sapaleMax chowbeyEli lillySun pharmaRybelsus ozempicDilip shanghviNovo nordisk wegovy ozempicVikrant shrotriyaZydus cadilaExpert committeeWorld health organization

The top 5 Best Places to Work in India for 2023 revealed, Novo Nordisk GBS ranks no 1

The top 5 Best Places to Work in India for 2023 revealed, Novo Nordisk GBS ranks no 1
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

Novo nordiskJohn dawberNovo nordisk global business servicesMedia outreach newswireNovo nordisk indiaBest placesPlatinum standardBest employersCorporate vice presidentManaging director

Indian pharma cos speed up anti-obesity drug development amidst high demand and Ozempic sales surge

Sun Pharma, Dr. Reddy's, Lupin, Torrent, and Zydus Cadila progressing obesity drug candidates in response to rising demand. Notable developments include Sun Pharma's Phase 1 studies and Dr. Reddy’s Laboratories' permission for a semaglutide bioequivalence study

United statesNovo nordisk ozempicZydus cadilaAnoop misraSun pharmaTina dengElon muskNovo nordiskVikrant shrotriyaReddy laboratories ltdF hoffmann la roche ltdOrexigen therapeutics incNational diabetesArena pharmaceuticals incEisai co ltdCholesterol foundation

Indian pharma cos speed up anti-obesity drug development amidst high demand and Ozempic sales surge

Indian pharma cos speed up anti-obesity drug development amidst high demand and Ozempic sales surge
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.

United statesNovo nordisk ozempicTina dengVikrant shrotriyaZydus cadilaNovo nordiskElon muskAnoop misraSun pharmaArena pharmaceuticals incCholesterol foundationSun pharmaceutical industries ltdReddy laboratories ltdOrexigen therapeutics incEisai co ltdVivus inc